About Index Trending news
Analyze
Pricing
bluebird bio

bluebird bio

Work at bluebird bio? Add yourself to this profile

bluebird bio

bluebird bio is developing innovative gene therapies for severe genetic disorders. Our vision is to make the hope of gene therapy a reality.

Elsewhere

Alexa global traffic share

Twitter followers

07 Dec 2016
$250,000,000
Post-IPO equity

Boston Business on Twitter

Twitter
27 Oct 2012
$9,300,000
Venture capital
California Institute for Regenerative Medicine
25 Jul 2012
$60,000,000
Venture capital (Series D)
20 Apr 2011
$30,000,000
Venture capital
12 Mar 2010
$35,000,000
Venture capital (Series B)